Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Anticancer Research

• Publication date

  2016-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.21873/ANTICANRES.11234PMID 27919958
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anthocyanin-containing purple-fleshed potatoes suppress colon tumorigenesis via elimination of colon cancer stem cells.

  2015cited by this paper
• RPS12 increases the invasiveness in cervical cancer activated by c-Myc and inhibited by the dietary flavonoids luteolin and quercetin

  2015cited by this paper
• Quercetin reduces pluripotency, migration and adhesion of human teratocarcinoma cell line NT2/D1 by inhibiting Wnt/β-catenin signaling.

  2014cited by this paper
• Impact of Flavonoids on Matrix Metalloproteinase Secretion and Invadopodia Formation in Highly Invasive A431-III Cancer Cells

  2013cited by this paper
• JNK Signaling in the Control of the Tumor-Initiating Capacity Associated with Cancer Stem Cells.

  2013cited by this paper
• Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics

  2012cited by this paper
• The evolving concept of cancer and metastasis stem cells

  2012cited by this paper
• Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog-Gli1 pathway.

  2012cited by this paper
• Targeting JNK for therapeutic depletion of stem-like glioblastoma cells

  2012cited by this paper
• c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells

  2012cited by this paper
• Abstract LB-204: Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential

  2012cited by this paper
• Anti-inflammatory and anti-angiogenic effects of flavonoids isolated from Lycium barbarum Linnaeus on human umbilical vein endothelial cells.

  2012cited by this paper
• Tubular network formation by adriamycin-resistant MCF-7 breast cancer cells is closely linked to MMP-9 and VEGFR-2/VEGFR-3 over-expressions.

  2012cited by this paper
• Contribution of cancer stem cells to tumor vasculogenic mimicry

  2011cited by this paper
• Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2‐mediated PI3K/Akt/mTOR signaling pathway

  2011cited by this paper
• Effects of dietary flavonoids, luteolin, and quercetin on the reversal of epithelial–mesenchymal transition in A431 epidermal cancer cells

  2011cited by this paper
• Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Matrix metalloproteinase‐9 cooperates with transcription factor Snail to induce epithelial–mesenchymal transition

  2011cited by this paper
• Vascular mimicry in cultured head and neck tumour cell lines

  2011cited by this paper
• Signalling pathways in vasculogenic mimicry.

  2010cited by this paper
• Matrix metalloproteinases: regulators of the tumor microenvironment.

  2010cited by this paper
• Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma.

  2010cited by this paper
• The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition

  2010cited by this paper
• Stem cell characteristics in prostate cancer cell lines.

  2010cited by this paper
• Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.

  2010cited by this paper
• Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

  2009cited by this paper
• Herbal Extract of Wedelia chinensis Attenuates Androgen Receptor Activity and Orthotopic Growth of Prostate Cancer in Nude Mice

  2009cited by this paper
• Enrichment of Cancer Stem Cells Based on Heterogeneity of Invasiveness

  2009cited by this paper
• MMP‐2 alters VEGF expression via αVβ3 integrin‐mediated PI3K/AKT signaling in A549 lung cancer cells

  2009cited by this paper
• Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature

  2009cited by this paper
• Tumor Environment Dictates Medulloblastoma Cancer Stem Cell Expression and Invasive Phenotype

  2008cited by this paper
• Investigation of MMP-2 and -9 in a highly invasive A431 tumor cell sub-line selected from a Boyden chamber assay.

  2008cited by this paper
• Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

  2008cited by this paper
• Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

  2008cited by this paper
• Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors

  2008cited by this paper
• Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

  2007cited by this paper
• Vasculogenic mimicry: current status and future prospects.

  2007cited by this paper
• Successful Therapy Must Eradicate Cancer Stem Cells

  2006cited by this paper
• Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells.

  2006cited by this paper
• Cancer stem cells: an old idea--a paradigm shift.

  2006cited by this paper
• Involvement of MAPK pathway in TNF-alpha-induced MMP-9 expression in human trophoblastic cells.

  2006cited by this paper
• Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns.

  2006cited by this paper
• Prospective identification of tumorigenic prostate cancer stem cells.

  2005cited by this paper
• The antitumor activities of flavonoids.

  2005cited by this paper
• Matrix metalloproteinases as therapeutic targets in cancer.

  2005cited by this paper
• Acute Myeloid Leukemia Stem Cells

  2005cited by this paper
• Transcriptional Regulation of Nanog by OCT4 and SOX2*

  2005cited by this paper
• EXPRESSION OF UBIQUITIN-SPECIFIC PROTEASE 14 IN HUMAN PANCREATIC CANCER CELL LINES AND CANCER TISSUES

  2005cited by this paper
• CD133, a novel marker for human prostatic epithelial stem cells

  2004cited by this paper
• Transinactivation of the epidermal growth factor receptor tyrosine kinase and focal adhesion kinase phosphorylation by dietary flavonoids: effect on invasive potential of human carcinoma cells.

  2004cited by this paper
• Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas.

  2004cited by this paper
• Flavonoids inhibit VEGF/bFGF‐induced angiogenesis in vitro by inhibiting the matrix‐degrading proteases

  2003cited by this paper
• Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin. Cancer Res., 9: 00-00, 2003.

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.

  2002cited by this paper
• Can mosaic tumor vessels facilitate molecular diagnosis of cancer?

  2001cited by this paper
• Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression.

  2001cited by this paper
• Global cancer statistics in the year 2000.

  2001cited by this paper
• Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

  2000cited by this paper
• The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.

  2000cited by this paper
• Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

  1999cited by this paper
• Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis‐associated properties in A431 cells overexpressing epidermal growth factor receptor

  1999cited by this paper
• Regulation of matrix metalloproteinase expression in tumor invasion

  1999cited by this paper
• Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.

  1980cited by this paper

• Allelopathic Potential and Cytotoxic, Genotoxic, and Antigenotoxic Effects of Tecoma stans Flowers (Bignoniaceae)

  2026cites this paper
• Breaking the bottlenecks in anti-tumor angiogenic therapy: targeting vasculogenic mimicry with natural products and traditional Chinese medicine

  2025cites this paper
• Molecular Mechanisms of Dietary Compounds in Cancer Stem Cells from Solid Tumors: Insights into Colorectal, Breast, and Prostate Cancer

  2025cites this paper
• EMT and cancer stem cells: Drivers of therapy resistance and promising therapeutic targets.

  2025cites this paper
• Natural products targeting cancer stem cells: a promising therapeutic approach

  2025cites this paper
• Anticancer Potential of Ampelopsis cantoniensis Extract: Inducing Apoptosis, Cell Cycle Arrest, and Targeting Cancer Stem Cells in HepG2 Liver Cancer Cells

  2025cites this paper
• Natural compounds from traditional Chinese medicine regulating stem cell fate: Identification and therapeutic potential

  2025cites this paper
• Revisiting luteolin: An updated review on its anticancer potential

  2024cites this paper
• The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens

  2024cites this paper
• Seedless black Vitis vinifera polyphenols suppress hepatocellular carcinoma in vitro and in vivo by targeting apoptosis, cancer stem cells, and proliferation.

  2024cites this paper
• Layer-by-layer assembly of quercetin-loaded zein/γPGA/low-molecular-weight chitosan/fucoidan nanosystem for targeting inflamed blood vessels.

  2024cites this paper
• A comprehensive review on the use of traditional Chinese medicine for cancer treatment

  2024cites this paper
• Curcumin Inhibits Vasculogenic Mimicry Via Regulating ETS-1 in Renal Cell Carcinoma.

  2024cites this paper
• Potent Suppression of Prostate Cancer Cell Growth and Eradication of Cancer Stem Cells by CD44-targeted Nanoliposome-quercetin Nanoparticles

  2023cites this paper
• Quercetin modulates signal transductions and targets non-coding RNAs against cancer development.

  2023cites this paper
• Investigation of the effect of rhamnetin on mice injected with solid and ehrlich ascites tumor

  2023cites this paper
• The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update

  2023cites this paper
• Therapeutic Potential of Luteolin on Cancer

  2023cites this paper
• Elucidating molecular and cellular targets and the antiprostate cancer potentials of promising phytochemicals: a review

  2023cites this paper
• Luteolin overcomes acquired resistance to osimertinib in non-small cell lung cancer cells by targeting the HGF-MET-Akt pathway.

  2023cites this paper
• Emerging insights of nutraceuticals as anticancer

  2023cites this paper
• Regulatory Roles of Flavonoids in Caspase-11 Non-Canonical Inflammasome-Mediated Inflammatory Responses and Diseases

  2023cites this paper
• Flavonoids target different molecules of autophagic and metastatic pathways in cancer cells

  2023cites this paper
• Diet-derived small molecules (nutraceuticals) inhibit cellular proliferation by interfering with key oncogenic pathways: an overview of experimental evidence in cancer chemoprevention

  2022cites this paper
• Flavonol Quercetin: Immunomodulatory And Anticancer Properties

  2022cites this paper
• Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy

  2022cites this paper
• Role of Plant-Derived Flavonoids in Cancer Treatment

  2022cites this paper
• Crosstalk between xanthine oxidase (XO) inhibiting and cancer chemotherapeutic properties of comestible flavonoids- a comprehensive update.

  2022cites this paper
• Total Flavones Isolated from Lycium Barbarum L. Inhibit the Proliferation, Migration and Invasion of GlioblastomaU-87MG Cells by Decreasing Formyl Peptide Receptor 1 Expression

  2021cites this paper
• Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated

  2021cites this paper
• Emerging impact of quercetin in the treatment of prostate cancer.

  2021cites this paper
• Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition

  2021cites this paper
• Comparative Analysis on Single- and Multiherb Strategies in Coronary Artery Atherosclerosis Therapy

  2021influential citation
• UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells

  2021cites this paper
• Targeting cancer stem cells by nutraceuticals for cancer therapy.

  2021cites this paper
• pH and electrolytes metabolism in prostate cancer

  2021cites this paper
• Luteolin attenuates cancer cell stemness in PTX-resistant oesophageal cancer cells through mediating SOX2 protein stability.

  2021cites this paper
• Modulation of Long Non-Coding RNAs by Different Classes of Secondary Metabolites from Plants: A Mini-Review on Antitumor Effects.

  2021cites this paper
• The role of quercetin in primary culture of ovine spermatogonial stem cells

  2021cites this paper
• Flavonoids Targeting Cancer Stem Cells: A Paradigm to Anticancer Efficacy

  2021cites this paper
• Flavonoids Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics

  2021cites this paper
• Molecular mechanism of luteolin against in�ammation based on integration of network pharmacology, transcriptomics and proteomics

  2020cites this paper
• Flavonoids in cancer therapy: current and future trends

  2020cites this paper
• A network pharmacology strategy to investigate the anti-inflammatory mechanism of luteolin combined with in vitro transcriptomics and proteomics.

  2020cites this paper
• Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets

  2020cites this paper
• Luteolin retards CXCL12-induced Jurkat cells migration by disrupting transcription of CXCR4.

  2020cites this paper
• Cuminum cyminum fruits as source of luteolin- 7-O-glucoside, potent cytotoxic flavonoid against breast cancer cell lines

  2020cites this paper
• The Effect of Resveratrol and Quercetin on Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem Cell

  2020cites this paper
• Luteolin, a flavonoid, as an anticancer agent: A review.

  2019cites this paper
• Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science

  2019cites this paper
• The Effect of Plant-Derived Compounds in Targeting Cancer Stem Cells

  2019cites this paper
• Flavonoids as Potential Anticancer Agents in Clinics: Where Have We Reached So Far?

  2019cites this paper
• Influence of luteolin on the apoptosis of esophageal cancer Eca109 cells and its mechanism of action

  2019cites this paper
• Current Aspects of Flavonoids: Their Role in Cancer Treatment

  2019cites this paper
• Antiproliferative potential and phenolic compounds of infusions and essential oil of chamomile cultivated with homeopathy.

  2019cites this paper
• Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment

  2019cites this paper
• Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier in Vitro

  2018cites this paper
• Flavonoids, bioactive components of propolis, exhibit cytotoxic activity and induce cell cycle arrest and apoptosis in human breast cancer cells MDA-MB-231 and MCF-7 - a comparative study.

  2018cites this paper
• Mechanism of metastasis suppression by luteolin in breast cancer

  2018cites this paper
• Luteolin induces myelodysplastic syndrome‑derived cell apoptosis via the p53‑dependent mitochondrial signaling pathway mediated by reactive oxygen species.

  2018cites this paper
• Anticancer activity of flavonoids isolated from Achyrocline satureioides in gliomas cell lines.

  2018cites this paper
• Expression of prostate stem cell antigen is downregulated during flavonoid-induced cytotoxicity in prostate cancer cells.

  2017cites this paper
• Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan

  2017cites this paper
• Baicalein suppresses the androgen receptor (AR)-mediated prostate cancer progression via inhibiting the AR N-C dimerization and AR-coactivators interaction

  2017cites this paper
• Selective Estrogen Receptor Modulator (SERM)-like Activities of Diarylheptanoid, a Phytoestrogen from Curcuma comosa, in Breast Cancer Cells, Pre-osteoblast Cells, and Rat Uterine Tissues.

  2017cites this paper
• Quercetin prevents alcohol-induced liver injury through targeting of PI3K/Akt/nuclear factor-κB and STAT3 signaling pathway.

  2017cites this paper
• Assessing the anticancer effects associated with food products and/or nutraceuticals using in vitro and in vivo preclinical development-related pharmacological tests.

  2017cites this paper
• Antiangiogenic Effect of Flavonoids and Chalcones: An Update

  2017cites this paper
• Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells

  2017cites this paper
• Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial

  2017cites this paper